首页> 外文期刊>Journal of molecular graphics & modelling >Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube
【24h】

Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube

机译:基于碳纳米管的壳聚糖用于药物递送系统的复制分子动力学模拟

获取原文
获取原文并翻译 | 示例
           

摘要

Chitosan is an important biopolymer in the medical applications because of its excellent biocompatibility. It has been recently highlighted in the targeted drug delivery system (DDS) by improvement of the carbon nanotube (CNT) solubility. To investigate the effect of chitosan length, the two targeted DDSs with 30 and 60 chitosan monomers were performed by replica-exchange molecular dynamics simulations at temperatures in the range of 300-455 K with three different combinations of force fields and implicit solvation models. Each DDS model contains the epidermal growth factor (EGF), chitosan (CS) of 30 (30CS) and 60 (60CS) monomers, single-wall CNT (SWCNT) and gemcitabine (Gemzar) as the model payload anticancer drug, called EGF/30CS/SWCNT/Gemzar and EGF/60CS/SWCNT/Gemzar, respectively. The SWCNT confines gemcitabine inside its cavity, while the outer surface is wrapped by chitosan in which one end is linked to the EGF. Even though the REMD results from different force fields and implicit solvation models are not exactly identical, all of them are in the same trend confirming that in the EGF/30CS/SWCNT/Gemzar DDS the 30CS chain was not long enough to wrap around the SWCNT, and consequently the EGF was located so close to the tube as to potentially cause steric inhibition of the binding of EGF to its receptor (EGFR), which is highly expressed on the surface of cancer cells. On the other hand, this phenomenon is not observed in the EGF/60CS/SWCNT/Gemzar DDS in which the 60CS was found to completely wrap over the CNT outer surface using only 50 chitosan units. The evidence suggested that a ratio of chitosan molecular weight per SWCNT surface area larger than 9.9 × 10~(-7) kg/m~2 is suitable for application in targeted DDSs. Although an increase in the temperature is likely to influence the overall DDS structure, and especially the orbit of helical chitosan on the SWCNT and the EGF conformation, gemcitabine is still encapsulated inside the tube.
机译:壳聚糖由于其优异的生物相容性,在医学应用中是重要的生物聚合物。最近,通过改善碳纳米管(CNT)的溶解度,在靶向药物递送系统(DDS)中突出了这一点。为了研究壳聚糖长度的影响,在300-455 K的温度范围内,通过三种不同的力场组合和隐式溶剂化模型,通过复制-交换分子动力学模拟,对具有30和60个壳聚糖单体的两个靶向DDS进行了研究。每个DDS模型都包含表皮生长因子(EGF),30(30CS)和60(60CS)单体的壳聚糖(CS),单壁CNT(SWCNT)和吉西他滨(Gemzar)作为模型有效载荷抗癌药,称为EGF / 30CS / SWCNT / Gemzar和EGF / 60CS / SWCNT / Gemzar。 SWCNT将吉西他滨限制在其腔内,而外表面则被壳聚糖包裹,其一端与EGF连接。即使来自不同力场的REMD结果和隐式溶剂化模型并不完全相同,但它们都处于同一趋势,这证实了在EGF / 30CS / SWCNT / Gemzar DDS中30CS链的长度不足以缠绕SWCNT因此,EGF的位置离试管很近,以至于潜在地引起EGF与其受体(EGFR)结合的空间抑制,该受体在癌细胞表面高表达。另一方面,在EGF / 60CS / SWCNT / Gemzar DDS中未观察到此现象,其中仅使用50个壳聚糖单元,发现60CS完全包裹在CNT外表面上。有证据表明,每SWCNT表面积的壳聚糖分子量比大于9.9×10〜(-7)kg / m〜2时,适合用于目标DDS。尽管温度升高可能会影响整个DDS结构,尤其是影响SWCNT和EGF构象的螺旋壳聚糖的轨道,但吉西他滨仍被包封在试管内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号